Lot Release Number |
2018-10-16-0235
|
FDA Registered Product/Generic Name |
QUADRIVALENT HUMAN PAPILLOMAVIRUS RECOMBINANT VACCINE (TYPES 6, 11, 16 AND 18)
|
Brand Name |
GARDASIL
|
Dosage Strength |
0.5 mL
|
Dosage Form |
Suspension for I.M. Injection
|
Registration Number |
BR-602
|
Batch/Lot Number |
817939
|
Packaging Lot |
Packaging lot: R026472; 25Gx1" Needle: 1806044, ED 2023-05-31; 23Gx1" Needle: 1806024, ED 2023-05-31
|
Product Expiration Date |
31 March 2021
|
Issuance Date |
22 October 2018
|